Search details
1.
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
N Engl J Med
; 388(19): 1739-1754, 2023 May 11.
Article
in English
| MEDLINE | ID: mdl-37163621
2.
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Blood
; 142(5): 446-459, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-37172204
3.
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.
Blood
; 139(2): 177-187, 2022 01 13.
Article
in English
| MEDLINE | ID: mdl-34758069
4.
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.
Eur J Haematol
; 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38693677
5.
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 109(6): 1973-1976, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38385304
6.
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Ann Hematol
; 98(4): 897-907, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30610279
7.
Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.
Br J Haematol
; 198(2): 401-404, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35538912
8.
Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia.
Am J Hematol
; 96(12): E457-E460, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34591989
9.
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial.
Nat Med
; 30(1): 240-248, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38071379
10.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Hemasphere
; 7(7): e904, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37427146
11.
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice.
Ther Adv Med Oncol
; 13: 17588359211012361, 2021.
Article
in English
| MEDLINE | ID: mdl-33995597
12.
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.
Leukemia
; 32(12): 2558-2571, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30275528
13.
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
J Clin Oncol
; 36(20): 2024-2034, 2018 07 10.
Article
in English
| MEDLINE | ID: mdl-29750632
Results
1 -
13
de 13
1
Next >
>>